[go: up one dir, main page]

PL3330370T3 - Sposób hodowania komórek cho - Google Patents

Sposób hodowania komórek cho

Info

Publication number
PL3330370T3
PL3330370T3 PL17199357T PL17199357T PL3330370T3 PL 3330370 T3 PL3330370 T3 PL 3330370T3 PL 17199357 T PL17199357 T PL 17199357T PL 17199357 T PL17199357 T PL 17199357T PL 3330370 T3 PL3330370 T3 PL 3330370T3
Authority
PL
Poland
Prior art keywords
cultivation
cho cells
cho
cells
Prior art date
Application number
PL17199357T
Other languages
English (en)
Inventor
Christoph E. Joosten
Christian Leist
Jörg Schmidt
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44041460&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3330370(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PL3330370T3 publication Critical patent/PL3330370T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/005Glycopeptides, glycoproteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14Specific host cells or culture conditions, e.g. components, pH or temperature
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/60Buffer, e.g. pH regulation, osmotic pressure
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • C12N2510/02Cells for production
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2523/00Culture process characterised by temperature

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
PL17199357T 2010-04-26 2011-04-25 Sposób hodowania komórek cho PL3330370T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US32784610P 2010-04-26 2010-04-26
EP17199357.9A EP3330370B1 (en) 2010-04-26 2011-04-25 Process for cultivation of cho cells
EP11715933.5A EP2563906B1 (en) 2010-04-26 2011-04-25 Process for cultivation of cho cells
PCT/EP2011/056507 WO2011134919A2 (en) 2010-04-26 2011-04-25 Improved cell cultivation process

Publications (1)

Publication Number Publication Date
PL3330370T3 true PL3330370T3 (pl) 2021-09-20

Family

ID=44041460

Family Applications (2)

Application Number Title Priority Date Filing Date
PL11715933T PL2563906T3 (pl) 2010-04-26 2011-04-25 Sposób hodowli komórek cho
PL17199357T PL3330370T3 (pl) 2010-04-26 2011-04-25 Sposób hodowania komórek cho

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL11715933T PL2563906T3 (pl) 2010-04-26 2011-04-25 Sposób hodowli komórek cho

Country Status (18)

Country Link
US (1) US8765413B2 (pl)
EP (3) EP3862423A1 (pl)
JP (2) JP5980772B2 (pl)
KR (1) KR101828624B1 (pl)
CN (2) CN107254499B (pl)
AU (1) AU2011246502B2 (pl)
BR (1) BR112012027430B1 (pl)
CA (1) CA2795461C (pl)
DK (2) DK3330370T3 (pl)
ES (2) ES2870469T3 (pl)
IL (1) IL222454B (pl)
LT (2) LT3330370T (pl)
MX (1) MX2012012528A (pl)
PL (2) PL2563906T3 (pl)
PT (2) PT3330370T (pl)
RU (1) RU2577972C2 (pl)
SG (1) SG185014A1 (pl)
WO (1) WO2011134919A2 (pl)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
EP2500413A1 (en) 2006-09-13 2012-09-19 Abbott Laboratories Cell culture improvements
NZ592097A (en) 2008-10-20 2013-01-25 Abbott Lab Viral inactivation during purification of il-12 and il-18 antibodies
KR20110091678A (ko) 2008-10-20 2011-08-12 아보트 러보러터리즈 단백질 a 친화성 크로마토그래피를 이용한 항체의 분리 및 정제
US8986957B2 (en) 2010-04-26 2015-03-24 Novartis Ag Cell culture medium
EP3862423A1 (en) 2010-04-26 2021-08-11 Novartis AG Improved cell cultivation process
EP2649176B1 (en) * 2010-12-07 2018-01-17 F. Hoffmann-La Roche AG Feed mixing device and its use
WO2012145682A1 (en) * 2011-04-21 2012-10-26 Amgen Inc. A method for culturing mammalian cells to improve recombinant protein production
EP2702077A2 (en) 2011-04-27 2014-03-05 AbbVie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
US10059770B2 (en) 2012-01-30 2018-08-28 Dr. Reddy's Laboratories Limited Process of modulating man5 and/or afucosylation content of a glycoprotein composition
WO2013158273A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Methods to modulate c-terminal lysine variant distribution
WO2013158279A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Protein purification methods to reduce acidic species
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
WO2013176754A1 (en) 2012-05-24 2013-11-28 Abbvie Inc. Novel purification of antibodies using hydrophobic interaction chromatography
BR112015004467A2 (pt) 2012-09-02 2017-03-21 Abbvie Inc método para controlar a heterogeneidade de proteínas
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
CN104822826B (zh) 2012-10-15 2019-04-30 百时美施贵宝公司 用于蛋白产生的哺乳动物细胞培养过程
CA2905010A1 (en) 2013-03-12 2014-09-18 Abbvie Inc. Human antibodies that bind human tnf-alpha and methods of preparing the same
WO2014151878A2 (en) 2013-03-14 2014-09-25 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
US8921526B2 (en) 2013-03-14 2014-12-30 Abbvie, Inc. Mutated anti-TNFα antibodies and methods of their use
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
EP3712252A1 (en) 2013-03-15 2020-09-23 F. Hoffmann-La Roche AG Cell culture compositions with antioxidants and methods for polypeptide production
AR095196A1 (es) 2013-03-15 2015-09-30 Regeneron Pharma Medio de cultivo celular libre de suero
KR101439195B1 (ko) 2013-04-18 2014-09-12 동아대학교 산학협력단 에셰리키아 콜리 a-53 균주를 이용하여 섬유소 분해효소의 생산성을 향상시키는 공정
HK1218297A1 (zh) * 2013-07-06 2017-02-10 Cadila Healthcare Limited 用於生产单克隆抗体的改进方法
US9598667B2 (en) 2013-10-04 2017-03-21 Abbvie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US8946395B1 (en) 2013-10-18 2015-02-03 Abbvie Inc. Purification of proteins using hydrophobic interaction chromatography
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
US20150139988A1 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
DK3110961T3 (da) 2014-02-27 2020-02-03 Hoffmann La Roche Modulering af cellevækst og glycosylering i rekombinant glycoproteinproduktion
RU2725191C2 (ru) 2014-08-11 2020-06-30 Ф. Хоффманн-Ля Рош Аг Способ повышения удельной скорости и продуцирования в эукариотических клетках
KR20160049390A (ko) 2014-10-27 2016-05-09 삼성전자주식회사 산알 배양용 조성물 및 이를 이용한 산알 배양 방법
CN107810194B (zh) 2015-05-22 2021-10-08 康诺贝林伦瑙有限公司 用于制备经修饰的血管性血友病因子的方法
HU231463B1 (hu) * 2015-08-04 2024-01-28 Richter Gedeon Nyrt. Módszer rekombináns proteinek galaktóz tartalmának növelésére
WO2017065559A1 (ko) 2015-10-15 2017-04-20 (주)알테오젠 Igg fc 도메인을 가지는 융합 단백질의 생산방법
KR101936049B1 (ko) * 2015-10-15 2019-01-08 (주)알테오젠 IgG Fc 도메인을 가지는 융합 단백질의 생산방법
WO2018018613A1 (zh) 2016-07-29 2018-02-01 广东东阳光药业有限公司 一种提高抗体纯度的细胞培养基和培养方法
JP7213180B2 (ja) 2016-10-19 2023-01-26 エフ.ホフマン-ラ ロシュ アーゲー 免疫コンジュゲートを製造するための方法
GB201708655D0 (en) 2017-05-31 2017-07-12 Ucb Biopharma Sprl Cell culture methods
EP3717656B1 (en) 2017-11-30 2024-03-13 F. Hoffmann-La Roche AG Process for culturing mammalian cells
EP3492582A1 (en) 2017-12-01 2019-06-05 UCB Biopharma SPRL Cell culture methods
CN109517738A (zh) * 2018-12-14 2019-03-26 杭州奕安济世生物药业有限公司 一种调控生物反应器中二氧化碳含量的方法
US12297451B1 (en) 2019-10-25 2025-05-13 Regeneron Pharmaceuticals, Inc. Cell culture medium
CN116391043A (zh) * 2020-08-14 2023-07-04 百时美施贵宝公司 蛋白质的制造方法
GB202012991D0 (en) 2020-08-20 2020-10-07 Ucb Biopharma Sprl Cell culture processes
JP2022060169A (ja) * 2020-10-02 2022-04-14 ファイザー・インク Rsv fタンパク質生産のための細胞培養工程
GB202105424D0 (en) 2021-04-16 2021-06-02 UCB Biopharma SRL Cell culture processes
KR20250100741A (ko) * 2022-11-09 2025-07-03 인포스 아게 응축을 방지하는 인큐베이터
GB202318647D0 (en) 2023-12-06 2024-01-17 Ucb Biopharma Sprl Cell culture processes

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8516415D0 (en) 1985-06-28 1985-07-31 Celltech Ltd Culture of animal cells
US5672502A (en) 1985-06-28 1997-09-30 Celltech Therapeutics Limited Animal cell culture
US5122469A (en) 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
GB9022545D0 (en) 1990-10-17 1990-11-28 Wellcome Found Culture medium
GB9118664D0 (en) 1991-08-30 1991-10-16 Celltech Ltd Cell culture
USH1532H (en) 1993-11-03 1996-05-07 Genetics Institute, Inc. Adaption of mammalian cell lines to high cell densities
US5856179A (en) 1994-03-10 1999-01-05 Genentech, Inc. Polypeptide production in animal cell culture
US6656466B1 (en) 1995-06-06 2003-12-02 Genetech, Inc. Human tumor necrosis factor—immunoglobulin(TNFR1-IgG1) chimera composition
JP4306813B2 (ja) 1995-09-19 2009-08-05 アスビオファーマ株式会社 動物細胞の新規培養方法
EP2243827B2 (en) 1996-08-30 2017-11-22 Life Technologies Corporation Serum-free mammalian cell culture medium, and uses thereof
US20020012991A1 (en) 1997-04-07 2002-01-31 Florence Chua Nee Ho Kit Fong Cell culture media for enhanced protein production
TR200504220T2 (tr) 1998-12-17 2007-04-24 Biogen Idec Ma Inc. Aktif limfotoksin-beta reseptör imunoglobülin şimeAktif limfotoksin-beta reseptör imunoglobülin şimerik proteinlerinin yüksek düzey ifadesi ve saflaştrik proteinlerinin yüksek düzey ifadesi ve saflaştırılması için bir yöntem.ırılması için bir yöntem.
RU2215748C2 (ru) * 1999-04-09 2003-11-10 Сентро Де Инмунология Молекулар Способ получения рекомбинантного эритропоэтина человека и полученный эритропоэтин, фармацевтическая композиция
EP1757700A3 (en) * 1999-04-26 2009-03-11 Genentech, Inc. Cell culture process for glycoproteins
AT409379B (de) 1999-06-02 2002-07-25 Baxter Ag Medium zur protein- und serumfreien kultivierung von zellen
AU2002256005A1 (en) 2001-03-27 2002-10-08 Smithkline Beecham Corporation Control of glycoforms in igg
CA2447791A1 (en) 2001-06-13 2002-12-19 Neslihan Delacruz Methods of culturing animal cells and polypeptide production in animal cells
CN1158388C (zh) * 2001-09-29 2004-07-21 陈志南 连续灌流式培养杂交瘤细胞制备抗体的方法
IL161858A0 (en) * 2001-11-28 2005-11-20 Sandoz Ag Cell culture process
US20030190710A1 (en) 2002-03-28 2003-10-09 Devries Ruth L. Control of glycoforms in IgG
US6924124B1 (en) 2002-08-23 2005-08-02 Immunex Corporation Feeding strategies for cell culture
KR101088223B1 (ko) 2002-12-23 2011-11-30 브리스톨-마이어스 스큅 컴퍼니 단백질 생산을 위한 포유류 세포 배양 방법에서의 생산물품질 향상
BR0317723A (pt) 2002-12-23 2005-11-22 Bristol Myers Squibb Co Processo de cultura de células de mamìfero para a produção de proteìna
US7294484B2 (en) 2004-08-27 2007-11-13 Wyeth Research Ireland Limited Production of polypeptides
TWI374935B (en) 2004-08-27 2012-10-21 Pfizer Ireland Pharmaceuticals Production of α-abeta
US7300773B2 (en) 2004-08-27 2007-11-27 Wyeth Research Ireland Limited Production of TNFR-Ig
DK2041270T3 (da) 2006-07-13 2014-01-27 Wyeth Llc Fremstilling af glycoproteiner
WO2008013809A1 (en) 2006-07-24 2008-01-31 Amgen Inc. Cell culture methods
EP2500413A1 (en) * 2006-09-13 2012-09-19 Abbott Laboratories Cell culture improvements
CA2666317C (en) 2006-11-03 2013-08-06 Wyeth Glycolysis-inhibiting substances in cell culture
KR101523782B1 (ko) 2006-11-08 2015-05-28 와이어쓰 엘엘씨 세포 배양을 위한 합리적으로 설계된 배지
AU2008232903B9 (en) 2007-03-30 2013-09-05 Medimmune Llc Antibodies with decreased deamidation profiles
TW200902708A (en) 2007-04-23 2009-01-16 Wyeth Corp Methods of protein production using anti-senescence compounds
TWI601823B (zh) * 2007-04-26 2017-10-11 Chugai Pharmaceutical Co Ltd Cell culture methods using media containing high concentrations of amino acids
CA2687082C (en) 2007-05-11 2014-01-14 Amgen Inc. Improved feed media
EP3862423A1 (en) 2010-04-26 2021-08-11 Novartis AG Improved cell cultivation process

Also Published As

Publication number Publication date
LT3330370T (lt) 2021-06-10
DK3330370T3 (da) 2021-05-10
KR101828624B1 (ko) 2018-02-12
JP2013524824A (ja) 2013-06-20
EP3330370B1 (en) 2021-02-24
EP2563906B1 (en) 2017-11-08
EP2563906A2 (en) 2013-03-06
RU2577972C2 (ru) 2016-03-20
EP3862423A1 (en) 2021-08-11
PT3330370T (pt) 2021-05-11
SG185014A1 (en) 2012-11-29
CN102858954A (zh) 2013-01-02
US8765413B2 (en) 2014-07-01
JP2016214254A (ja) 2016-12-22
WO2011134919A2 (en) 2011-11-03
ES2870469T3 (es) 2021-10-27
IL222454A0 (en) 2012-12-31
ES2659117T3 (es) 2018-03-13
RU2012150283A (ru) 2014-06-10
IL222454B (en) 2018-11-29
PL2563906T3 (pl) 2018-04-30
CN107254499A (zh) 2017-10-17
US20130130316A1 (en) 2013-05-23
JP5980772B2 (ja) 2016-08-31
EP3330370A1 (en) 2018-06-06
WO2011134919A3 (en) 2013-01-24
LT2563906T (lt) 2018-02-26
PT2563906T (pt) 2018-02-16
KR20130094723A (ko) 2013-08-26
CA2795461C (en) 2018-04-24
MX2012012528A (es) 2012-11-23
CA2795461A1 (en) 2011-11-03
AU2011246502B2 (en) 2014-08-28
BR112012027430A2 (pt) 2015-09-22
BR112012027430B1 (pt) 2020-04-07
CN107254499B (zh) 2021-09-17
DK2563906T3 (en) 2018-02-05

Similar Documents

Publication Publication Date Title
PT2563906T (pt) Processo para cultivo de células cho
TWI563079B (en) Process for fermentation of syngas
EP2729561A4 (en) CELL CULTURE METHOD
IL224321B (en) Methods for detecting diseases or conditions using phagocytic cells
PL2609120T3 (pl) Ulepszony sposób wytwarzania sugammadeksu
EP2545178A4 (en) ACIDIFICATION BY FERMENTATION
PL3825690T3 (pl) Sposób hodowli pojedynczych limfocytów b
GB201110042D0 (en) Growth of cells
SG10201601434RA (en) Cell Culture System
IL227185B (en) A method for growing animal cells
EP2600413A4 (en) Process for production of solar cell
IL223663A (en) Method for collecting algae
ZA201208686B (en) Microalgae growth pond design
EP2650375A4 (en) PROCESS FOR THE PRODUCTION OF CHEMICALS BY CONTINUOUS FERMENTATION
IL228546A0 (en) fermentation process
ZA201304024B (en) Fermentation process involving adjusting specific co-uptake
GB201020333D0 (en) Plant growing unit
EP2636730A4 (en) METHOD FOR OPEN CULTIVATION OF SILKETS
PT2454291E (pt) Processo de preparação de poliolefinas
ZA201402773B (en) Use of phenylpyrazolin-3-carboxylates for improving plant yield
ZA201401439B (en) Use of 5-phenyl-or 5-benzyl-2isoxazoline-3carboxylates for improving plant yield
GB2481212B (en) Apparatus for biogas production
PL2760978T3 (pl) Sposób wytwarzania biogazu
DK2591119T4 (da) Fermenteringsproces
PL2571600T3 (pl) Proces otrzymywania alkoholu